Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls (NCT00867464)

🧪 Interventions in This Study

• Cytology Specimen Collection Procedure (OTHER)
• Laboratory Biomarker Analysis (OTHER)
• Long-term Follow-up (OTHER)
• Questionnaire Administration (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Agencia Costarricense de Investigaciones Biomédicas (ACIB) — Liberia, Guanacaste Province

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Anal Carcinoma

• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers — Los Angeles, California
• Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy — Columbus, Ohio
• Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men — Los Angeles, California
• Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer — Columbus, Ohio
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers — La Jolla, California

Explore by condition: All Anal Carcinoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.